Call for Papers: Thematic Series 2019
Series Title: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.
Molecular Cancer is delighted to present this series that aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. Some areas of interest include, but are not limited to, hypoxia, microvesicles/exosomes, chemokines, carcinoma associated fibroblasts, tumor-infiltrating lymphocytes, and tumor associated macrophages and the clinical applications/drug development to target the TME and tumor cells.
We welcome submission of research articles, letters to the editor, and original reviews. The submission deadline is December 20th, 2018. To submit your manuscript, please use our online submission system available here.
When finalizing the submission, use the drop-down menu in the 'Additional Information' tab to specify that you are submitting to this special issue.
Aims and scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Molecular Cancer has an Impact Factor of 7.776 and is ranked in the top 10% of both its JCR Categories.
It is currently ranked at 27 out of 292 (Q1) in the Biochemistry and Molecular Biology category and 22 out of 222 (Q1) in the Oncology category of Journal Citation Reports.
2017 Journal Metrics
64 days to first decision for reviewed manuscripts only
46 days to first decision for all manuscripts
150 days from submission to acceptance
16 days from acceptance to publication
Social Media Impact